Events
5 minute read

Patent Term Adjustment and Patent Term Extension: Understanding the Practical Impact of this Year’s Game Changing Cases

Kevin E. Noonan, Ph.D.January 13, 20154:30 pm - 5:30 pm

MBHB partner Dr. Kevin Noonan is a featured presenter at the American Conference Institute’s Advanced Summit on Life Sciences Patents set for January 13-14, 2015 in New York City.


Details for Dr. Noonan’s presentation are as follows:


Tuesday, January 13 – 4:30-5:30 p.m. ET


It’s All about How Many Days, Months, Years are Left. . . Patent Term Adjustment and Patent Term Extension: Understanding the Practical Impact of this Year’s Game Changing Cases




  • Overview of the Novartis v. Lee decision



    • How has the USPTO implemented the decision?


    • What repercussions from the rulemaking are impacting lifecycle management?


  • Implementation of the AIA technical amendments to the Patent Term Adjustment statutes



    • Discussion of USPTO rules


    • Effect of change on patents granted before applicability date


  • Effect of Gilead v. Natco on PTA and subsequently earned PTE



    • Analyzing the interplay between Patent Term Extensions (PTE), changes in double patenting type obviousness case, and terminal disclaimer


    • Laying the groundwork for patent term restoration in light of evolving case law


    • Factoring PTA considerations into the decision whether or not to file a terminal disclaimer and available PTE

 


About American Conference Institute


American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world. Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.


View complete details here